Skip to content

Effect Of Nalbuphine as adjuvant in epidural block

Effect of addition of Nalbuphine Hydrochloride To Bupivacaine on post-operative analgesia In lower limb surgery Under Epidural block.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037198
Enrollment
40
Registered
2021-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: injection nalbuphine 1ml (10mg) with bupivacaine 0.5% (15ml): The drug combination {injection nalbuphine 1ml (10mg) with bupivacaine 0.5% (15ml) } is administered single shot epidurally

Sponsors

Srishti Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I & II ALL PATIENTS SCHEDULED FOR LOWER LIMB SURGERIES

Exclusion criteria

Exclusion criteria: 1.patients refusal for the procedure 2.ASA grade III & IV 3.patient with known hypersensitivity to study drug 4.patients with difficulty in communication 5.patients with severe systemic disease like respiratory, cardiac, hpatic, renal disease 6.patient with neurological, psychiatric or neurovacular disorders 7. patients with any contraindication for regional anesthesia like bleeding disorders raised intracranial tension 8. history of spine surgery and spinal deformity 9.pregnant and lactating patients

Design outcomes

Primary

MeasureTime frame
Pain Score (Visual analogue score)Timepoint: more than 5 (1-10 normal range)

Secondary

MeasureTime frame
side effects if anyTimepoint: Introperatively, 24 hours and 48 hours postoperatively;duration of analgesiaTimepoint: 48 hours post operatively;Requirement of rescue analgesicTimepoint: Introperatively, 24 hours and 48 hours postoperatively

Countries

India

Contacts

Public ContactDr Srishti Gupta

R D Gardi medical college

meeras1955@gmail.com9479858451

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026